Pharmaceutical News

RSS

Moderna COVID-19 vaccine effective in children five and under

mRNA-1273 vaccine (Moderna) shows strong effectiveness in reducing symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years. Further research is needed to explore long-term effectiveness and the potential need for booster doses.

5 Jul 2023

Less than half of approved new drugs add substantial therapeutic value over existing treatments

New drugs are often used not only for one disease (first approved indication) but also for other diseases (supplemental indications).

5 Jul 2023

Medical cannabis laws have no effect on opioid prescriptions, study finds

State laws allowing medical cannabis use did not reduce prescriptions for opioids or other therapies for chronic, non-cancer pain, according to a policy analysis by Weill Cornell Medicine investigators.

5 Jul 2023

Patients squeezed in fight over who gets to bill for pricey infusion drugs

Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country.

5 Jul 2023

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

Anti-amyloid immunotherapies for Alzheimer's disease require thorough evaluation of their efficacy, safety, and cost-effectiveness. Key questions regarding statistical analyses, treatment effects, and disease course modification guide evidence-based consideration of these drugs.

4 Jul 2023

A novel RSV vaccine that could be effective across all ages

Researchers evaluate the in vivo efficacy of a respiratory syncytial virus vaccine in old and young rats.

4 Jul 2023

New oral films could revolutionize drug delivery for patients

Conventional ways of administering medication - by swallowing tablets, consuming bitter syrups, injections or rectal insertions - could be distressing and unpleasant for some patients, especially young children or the elderly.

3 Jul 2023

CRISPR/Cas9-based screening identifies potential therapies for non-alcoholic fatty liver disease

Activation of the NRF2 transcription factor shows promise as a potential treatment approach for non-alcoholic fatty liver disease (NAFLD), a condition associated with oxidative stress and liver damage. By screening FDA-approved drugs, researchers identified six compounds that enhanced NRF2 activity and demonstrated protective effects against oxidative stress and lipid accumulation.

3 Jul 2023

Breaking the myth: opioids provide no advantage for acute back pain, study finds

The first placebo-controlled trial of opioids in acute low back and neck pain.

3 Jul 2023

Need to get Plan B or an HIV test online? Facebook may know about it

Looking for an at-home HIV test on CVS' website is not as private an experience as one might think. An investigation by The Markup and KFF Health News found trackers on CVS.com telling some of the biggest social media and advertising platforms the products customers viewed.

30 Jun 2023

Study reviews the status of microbial succinic acid production

The current status and future perspectives on the successful industrialization of biobased succinic acid are discussed in a comprehensive review article in the peer-reviewed journal Industrial Biotechnology.

30 Jun 2023

UTHSC College of Pharmacy ranked No. 6 in annual research funding from the NIH

The College of Pharmacy at the University of Tennessee Health Science Center is now ranked No. 6 in annual research funding from the National Institutes of Health, according to a new listing published by the American Association of Colleges of Pharmacy of its approximately 140 member institutions.

29 Jun 2023

Natural molecule could be added to toothpastes and mouthwashes to improve dental hygiene

Most of the world's population either chronically suffers from plaque and dental cavities or will develop them at some point in their lives.

29 Jun 2023

Study shows promising prospects for automating 3D-DSRT in drug testing

The June 2023 issue of SLAS Discovery contains one review article, five full-length articles and two technical briefs covering spheroid models, 3D cell high-throughput screening (HTS) applications for treating Alzheimer's and other drug discovery research.

29 Jun 2023

MDXX drugs: A promising new therapy for autism spectrum disorder

A new review in the peer-reviewed journal Psychedelic Medicine describes the complex pharmacology of methylenedioxy amphetamine analogs, or MDXX drugs, and how they may help treat autism spectrum disorder (ASD).

29 Jun 2023

eTRANSAFE: European project to share data on the safety of medicines

eTRANSAFE, the European project to share data on the safety of medicines, has come to fruition. On a single platform, the project has integrated data from more than 10,000 pharmacological studies by reference pharmaceutical companies, from a dozen databases that amass public and private information of clinical and preclinical studies.

29 Jun 2023

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

Researchers performed a double-blinded, placebo-controlled phase III randomized clinical trial (RCT).

29 Jun 2023

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Researchers performed a phase II randomized clinical trial (RCT).

29 Jun 2023

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Researchers performed a phase III randomized clinical trial (RCT).

29 Jun 2023

Pandemic paralysis: COVID-19 halts neglected tropical disease campaigns, study reveals solutions

In a recent study published in the journal PLoS Neglected Tropical Diseases, researchers evaluated the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on mass drug administration (MDA) programming. They also provided solutions by neglected tropical disease (NTD) stakeholders for the relaunch of MDA implementation activities.

28 Jun 2023

Previous
1
...
56
57
58
59
60
61
62
...
1443
Next

Pharmaceutical News

Moderna COVID-19 vaccine effective in children five and under

Less than half of approved new drugs add substantial therapeutic value over existing treatments

Medical cannabis laws have no effect on opioid prescriptions, study finds

Patients squeezed in fight over who gets to bill for pricey infusion drugs

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

A novel RSV vaccine that could be effective across all ages

New oral films could revolutionize drug delivery for patients

CRISPR/Cas9-based screening identifies potential therapies for non-alcoholic fatty liver disease

Breaking the myth: opioids provide no advantage for acute back pain, study finds

Need to get Plan B or an HIV test online? Facebook may know about it

Study reviews the status of microbial succinic acid production

UTHSC College of Pharmacy ranked No. 6 in annual research funding from the NIH

Natural molecule could be added to toothpastes and mouthwashes to improve dental hygiene

Study shows promising prospects for automating 3D-DSRT in drug testing

MDXX drugs: A promising new therapy for autism spectrum disorder

eTRANSAFE: European project to share data on the safety of medicines

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Pandemic paralysis: COVID-19 halts neglected tropical disease campaigns, study reveals solutions

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News